Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Asymchem Laboratories Co Ltd announced today that it has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich Kent UK
The American Society for Transplantation and Cellular Therapy applauds the US Food and Drug Administrations accelerated approval of TECELRA for the treatment
On July the US FDA approved Alpha Cognition Incs ALPHA Zunveyl an Acetylcholinesterase AChE inhibitor for treating mildtomoderate Alzheimers disease This condition affects approximately million people in the United States Over of physicians are d...
On June the US FDA approved AstraZenecas Durvalumab IMFINZI for primary advanced or recurrent endometrial cancer with mismatch repair deficiency Endometrial cancer is the most prevalent gynecologic cancer with an estimated new US cases in This ap...
NurExone Biologic Inc a pioneering biopharmaceutical company is thrilled to announce an important milestone in its regenerative medicine efforts The Company has successfully transferred the manufacturing of the small interfering
Instil Bio Inc and ImmuneOnco Biopharmaceuticals Inc today announced a definitive agreement pursuant to which Instil is inlicensing ex China development and commercial rights
Hitachi HighTech Corporation and Nabsys LLC announced today that Hitachi HighTech has acquired a majority interest in Nabsys a developer and manufacturer of instrumentation and consumables for the analysis of genomic structural variation This transa...
Chugai Pharmaceutical Co Ltd announced that Chugai Pharma Taiwan Ltd a whollyowned subsidiary of Chugai obtained an import drug license from the Taiwan Food and Drug Administration
Boston Oncology and King Fahd Medical City are joining forces under a major initiative to transform healthcare in the Kingdom of Saudi Arabia signed a letter of intent to collaborate on localization of cell
Chugai Pharmaceutical Co Ltd announced today that it has concluded a license agreement with F HoffmannLa Roche Ltd for inavolisib a PIK alpha inhibitor currently in development for advanced
